Axsome Therapeutics Inc. (1AXSM)
MTA
Closed
Oct 2, 2026
Day's Range
166.0052 wk Range
104.10Overview - 1AXSM - Axsome Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
7.83B
P/E (Trailing)
‪-46.80‬
PEG Ratio
‪-22.70‬
Price / Sales (TTM)
‪11.61‬
Price / Book
‪123.06‬
EV / EBITDA
‪-51.62‬
Profitability
Gross Margin
‪93.78%‬
Profit Margin
‪-24.67%‬
Operating Margin
‪-23.41%‬
Return on Assets
‪-16.31%‬
Return on Equity
‪-245.10%‬
Ownership
Shares Outstanding
52.29M
Float
44.46M
Held by Insiders
‪15.08%‬
Held by Institutions
‪74.59%‬
Price stats
Beta
‪0.70‬
50-Day Avg
‪189.19‬
200-Day Avg
‪172.63‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1AXSM - Axsome Therapeutics Inc.
Peers - 1AXSM - Axsome Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1AXSMMTAAxsome Therapeutics Inc.8.19BMarket Cap+39.56%52-week change-46.81P/E (Trailing)‪-24.67%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated Common Stock107.27BMarket Cap+27.72%52-week change30.40P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals, Inc.73.52BMarket Cap+30.66%52-week change19.47P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals, Inc.45.81BMarket Cap-73.35%52-week change43.84P/E (Trailing)‪16.12%‬Profit Margin
- 1INSMMTAInsmed Incorporated30.28BMarket Cap-19.46%52-week change-16.17P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-40.10%52-week change42.38P/E (Trailing)‪13.01%‬Profit Margin
- 1INCYMTAIncyte Corp.17.89BMarket Cap+32.92%52-week change15.77P/E (Trailing)‪27.70%‬Profit Margin
Profile Summary - 1AXSM - Axsome Therapeutics Inc.
About
Axsome Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing therapies for central nervous system disorders. Its marketed products include Auvelity for major depressive disorder, Sunosi for excessive daytime sleepiness related to narcolepsy or obstructive sleep apnea, and Symbravo…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
